Status
Conditions
Treatments
Study type
Funder types
Identifiers
About
Individuals with Auditory Neuropathy Spectrum Disorders (ANSD) represent 1-10% of adults with hearing loss. These individuals have little or no benefit from current hearing aids because ANSD is a continuum of hearing impairments due to synaptic or neural dysfunction in the peripheral and central parts of the auditory pathways, which impairs temporal information processing without necessarily affecting auditory sensitivity. There is a need to find ad-hoc denoising methods, based on the expert knowledge of audiologists, to improve the noise comprehension performance of these patients. Implemented denoising methods, based on artificial intelligence, will also greatly benefit more standard hearing loss cases.
Full description
Longitudinal study consisting of multiple visits with multiple examinations over a total duration of approximately 3 years per ANSD participant and 1 year per normal hearing participant.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
For all participants:
For participants with TSNA:
For controls:
Exclusion criteria
For all participants:
Primary purpose
Allocation
Interventional model
Masking
40 participants in 1 patient group
Loading...
Central trial contact
Marta Campi, PhD; Paul Avan, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal